ArticleJournal of inflammation research2026
Development of Machine Learning-Based Models to Predict Mortality in Intensive Care Unit Patients with Sepsis.
Article in Journal of inflammation research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: This study aimed to develop and validate a predictive model using machine learning to estimate mortality among intensive care unit patients. Methods: The medical records of 874 sepsis patients hospitalized at the Affiliated Hospital of Chengde Medical University from 2021 to 2024 were retrospectively analyzed. Sepsis patients were randomly divided into training and validation sets in a 7:3 ratio. We constructed mortality prediction models for sepsis patients using machine learning algorithms, including extreme gradient boosting (XGBoost), logistic regression (LR), random forest (RF), adaptive boosting (AdaBoost), k-nearest neighbors (KNN), support vector machine (SVM), multilayer perceptron (MLP), and Gaussian naive Bayes (GNB). The predictive performance of the machine learning models was assessed using receiver operating characteristic (ROC) curves, calibration curves, and decision curve analysis (DCA). This study was reported in accordance with the RECORD (REporting of studies Conducted using Observational Routinely collected health Data) guidelines. Results: A total of 874 patients with sepsis were included, of whom 338 died and 536 survived. Significant differences were observed between the mortality and survival groups with respect to platelet count (PLT), platelet distribution width (PDW), platelet distribution width to count ratio (PCR), mean platelet volume (MPV), monocyte count (Mono), albumin (Alb) level, total bilirubin (Tbil), alanine aminotransferase (ALT), aspartate aminotransferase (AST), lactate dehydrogenase (LDH), serum creatinine (Scr), blood urea nitrogen (BUN), fibrinogen (Fib) level, D-dimer level, lactate (Lac) level, respiratory system infection, gastrointestinal system infection, and APACHEII score. The ROC curve analysis showed that the areas under the curve (AUC) of the XGBoost, LR, RF, AdaBoost, KNN, SVM, MLP and GNB models in predicting the in-hospital mortality rate of sepsis patients were 0.954, 0.880, 0.951, 0.901, 0.859, 0.910, 0.836 and 0.854, respectively. Among the nine algorithms, the XGboost model performed significantly better than the others, achieving an accuracy of 0.879, a sensitivity of 0.734, and an F1 score of 0.821. The calibration curve demonstrated that the XGBoost model showed the best performance among the eight algorithms, with predictions closely matching the observed outcomes. Decision curve analysis indicated that the XGBoost model outperformed both extreme strategies. Conclusion: Machine learning models provide a reliable approach for predicting in-hospital mortality in patients with sepsis. Among them, the XGboost model demonstrated the highest predictive performance, aiding clinicians in identifying high-risk patients with sepsis and implementing early interventions to reduce mortality.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.